Gufic Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
GUFICBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gufic Biosciences has informed the stock exchanges that the trading window for dealing in its securities will be closed for designated persons and their immediate relatives from Tuesday, July 01, 2025 until 48 hours after the declaration of its Q1 FY26 (quarter ended June 30, 2025) unaudited financial results, both standalone and consolidated. This is a routine compliance filing under SEBI's Prohibition of Insider Trading Regulations, 2015, aimed at preventing insider trading ahead of the results announcement. The company has not yet disclosed the date of the board meeting that will consider and approve these quarterly results, stating it will be communicated in due course.
No direct impact on shareholders or stock price. This is a standard regulatory disclosure that simply signals the upcoming release of Q1 FY26 earnings — investors should watch for the board meeting date announcement and the results themselves in the coming weeks.